TickerFacts.

Biovie Inc. (BIVI): Operating Income

Annual figures by period end, from SEC filings.

-$22.65M
Year ended 2026-06-30
2015-06-30: -$233.4K2016-06-30: -$432.0K2017-06-30: -$1.55M2018-06-30: -$2.37M2019-06-30: -$2.50M2020-06-30: -$2.69M2021-06-30: -$138.05M2022-06-30: -$27.25M2023-06-30: -$45.08M2024-06-30: -$32.18M2025-06-30: -$18.07M2026-06-30: -$22.65M-$22.65M
2015-06-30 Operating Income (USD) 2026-06-30
Period endedOperating IncomeChange YoYSource filing
2026-06-30-$22.65Mn/m2026-08-13, From 2025-07-01
2025-06-30-$18.07Mn/m2026-08-13, From 2024-07-01
2024-06-30-$32.18Mn/m2025-08-15, From 2023-07-01
2023-06-30-$45.08Mn/m2024-09-30, From 2022-07-01
2022-06-30-$27.25Mn/m2023-08-16, From 2021-07-01
2021-06-30-$138.05Mn/m2022-09-27, From 2020-07-01
2020-06-30-$2.69Mn/m2021-08-30, From 2019-07-01
2019-06-30-$2.50Mn/m2020-08-07, From 2018-07-01
2018-06-30-$2.37Mn/m2019-09-27, From 2017-07-01
2017-06-30-$1.55Mn/m2018-10-05, From 2016-07-01
2016-06-30-$432.0Kn/m2017-08-24, From 2015-07-01
2015-06-30-$233.4Kn/a2016-09-28, From 2014-07-01

Operating Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Biovie Inc. (BIVI)2026-06-30-$22.65Mn/m
Exicure, Inc. (XCUR)2025-12-31-$4.23Mn/m
Actuate Therapeutics, Inc. (ACTU)2025-12-31-$22.50Mn/m
CytoDyn Inc. (CYDY)2026-05-31-$38.58Mn/m
Chemomab Therapeutics Ltd. (CMMB)2025-12-31-$112.00Mn/m
CalciMedica, Inc. (CALC)2025-12-31-$23.12Mn/m
Cellectar Biosciences, Inc. (CLRB)2025-12-31-$22.98Mn/m
Edesa Biotech, Inc. (EDSA)2025-09-30-$7.91Mn/m
Cingulate Inc. (CING)2025-12-31-$19.94Mn/m

Compare BIVI, XCUR, ACTU, CYDY side by side · Screen every company in Pharmaceutical Preparations ↗